4403.T
NOF Corporation

Basic Materials · Specialty Chemicals · valued as of 2026-11-03 · statements 2026-03-31

Average Intrinsic Value

3.52B USD

Market Cap

3.58B USD

Margin of Safety

-1.8%

Intrinsic / Market Ratio

0.98×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

3.79B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

3.10B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

3.67B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

3.52B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

3.52B USD

from the sum above

Market Cap

3.58B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.98×

the ratio the screener ranks by; Margin of Safety -1.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 3.79B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)3.27B USD
+②Net Cash Today521.19M USD
+③Growth Value0 USD
=Value3.79B USD

EPV of the Operations (NOPAT over WACC)

3.27B USD

Net cash today

+521.19M USD

Growth Value

0 USD

Value

3.79B USD

①EPV (earnings power value)

3.27B USD

②Net Cash Today

521.19M USD

③Growth Value

0 USD

Market value

Market Cap3.58B USD

The price on the date above times the shares.

Value vs market

Margin of Safety+5.3%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 3.10B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE1.82B USD
+②Equity at Year 15, Today1.28B USD
=Value3.10B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

1.82B USD

②Equity at Year 15, Today

1.28B USD

Market value

Market Cap3.58B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-15.6%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 3.67B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF1.91B USD
+②Invested Capital at Year 15, Today1.24B USD
+③Net Cash Today521.19M USD
=Value3.67B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

1.91B USD

②Invested Capital at Year 15, Today

1.24B USD

③Net Cash Today

521.19M USD

Market value

Market Cap3.58B USD

The price on the date above times the shares.

Value vs market

Margin of Safety+2.4%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.59%
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.35×Market Risk Premium 6.00%= 6.63%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 104.40M USDPretax Income 359.02M USD= 29.08%

The tax the interest saves.

Interest Expense =EBIT 359.93M USD−Pretax Income 359.02M USD= 908.06K USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 908.06K USDTotal Debt 32.18M USD×(1 − Tax Rate for WACC 29.08%)= 2.00%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 32.18M USDMarket Cap + Total Debt 3.58B USD + 32.18M USD= 0.89%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.11%×Cost of Equity 6.63%+Debt Weight 0.89%×Cost of Debt 2.00%= 6.59%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 2.50B USD − Total Liabilities 643.18M USD = Book Value Today 1.86B USD

Total Debt 32.18M USD − Cash and Short-Term Investments 553.38M USD = Net Debt Today -521.19M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-5.2%at most 5%passes226,434,665 / 238,955,745
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets-1.2%at least -10.0%passes(224.60M USD − 253.94M USD) ÷ 2.50B USD
Price to bookMarket Cap ÷ Book Value Today1.93×at most 3×passes3.58B USD ÷ 1.86B USD
Operating marginOperating Income ÷ Revenue18.4%above 10.0%passes296.91M USD ÷ 1.62B USD
Revenue growthRevenue ÷ Revenue a Year Before − 11.3%above 10.0%does not pass1.62B USD / 1.59B USD
Net cash(Cash − Total Debt) ÷ Market Cap14.5%above -30%passes(553.38M USD − 32.18M USD) ÷ 3.58B USD
Operating efficiencyOperating Income ÷ Gross Profit53.2%above 25.0%passes296.91M USD ÷ 557.94M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

2512.51 JPY

Enterprise value

505.15B JPY

the provider's own figure

EV / EBITDA

7.03×

Price / book

1.92×

the provider's book

Price / earnings

14.23×

Return on equity

13.8%

the provider's figure, not this page's

Profit margin

14.6%

Revenue growth

23.1%

Analyst target, mean

3623.62 JPY

Analysts

5

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2023202420252026
Income statement

Revenue

1.64B1.47B1.59B1.62B

Gross profit

570.71M525.42M569.71M557.94M

Operating income

305.30M278.55M303.13M296.91M

EBITDA

operating income before depreciation and amortisation

409.41M367.09M393.93M498.43M

Pretax income

361.02M320.37M339.73M359.02M

Net income

255.31M224.67M244.18M253.94M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

230.06M212.06M225.05M224.88M

R&D

————
Balance sheet, year end

Total assets

2.33B2.26B2.39B2.50B

Total liabilities

521.82M499.33M519.49M643.18M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

1.80B1.75B1.86B1.85B

Total debt

36.39M34.14M33.73M32.18M

Cash and equivalents

695.28M606.42M582.49M553.38M

Net PP&E

fixed assets after depreciation

479.93M493.72M569.15M605.74M

Working capital

current assets less current liabilities

1.07B996.33M1.03B943.03M
Cash flow

Operating cash flow

175.35M198.10M193.85M224.60M

Capital expenditure

paid out, so below zero

-46.74M-117.31M-109.29M-90.12M

Depreciation and amortisation

47.79M45.87M53.29M138.50M

Free cash flow

operating cash flow plus capital expenditure

128.61M80.79M84.56M134.48M